Outaouais Memory Clinic
Clinique Mémoire is a multidisciplinary medical center specializing in memory problems. It aims to help patients recognize and detect early signs of memory issues, potentially mitigating their effects. The clinic collaborates closely with individuals affected by Alzheimer's disease to provide personalized care and improve quality of life. Research is a key component of their approach, with a focus on advancing knowledge and treatments for Alzheimer's and other neurodegenerative disorders.
Industries
Nr. of Employees
medium (51-250)
Outaouais Memory Clinic
Gatineau, Quebec, Canada, North America
Products
Évaluation de la mémoire et dépistage des troubles cognitifs
Service d'évaluation clinique et de dépistage précoce des troubles de la mémoire destiné aux personnes de 50 ans et plus.
Clinique de la mémoire
A memory assessment and clinical service providing confidential memory evaluations and cognitive screening.
Testez votre mémoire
Un test de mémoire interactif en ligne conçu pour évaluer la rétention de mots après une période de distraction.
Évaluation de la mémoire et dépistage des troubles cognitifs
Service d'évaluation clinique et de dépistage précoce des troubles de la mémoire destiné aux personnes de 50 ans et plus.
Clinique de la mémoire
A memory assessment and clinical service providing confidential memory evaluations and cognitive screening.
Testez votre mémoire
Un test de mémoire interactif en ligne conçu pour évaluer la rétention de mots après une période de distraction.
Services
Clinical evaluation including medical questionnaire, medication review, cognitive testing and collateral history to assess memory and cognitive function.
Recruitment and conduct of clinical research programs for investigational therapies, including informed consent, protocol implementation and safety monitoring.
Laboratory preparation of clinical samples and an on-site pharmacy to prepare and store investigational products according to specified storage/temperature requirements.
Provision of eSource and eRegulatory systems that allow partners real-time access to study data and regulatory records.
Organization and hosting of informational talks, webinars and participation in community events to provide education on brain health, risk factors and research participation.
Clinical evaluation including medical questionnaire, medication review, cognitive testing and collateral history to assess memory and cognitive function.
Recruitment and conduct of clinical research programs for investigational therapies, including informed consent, protocol implementation and safety monitoring.
Laboratory preparation of clinical samples and an on-site pharmacy to prepare and store investigational products according to specified storage/temperature requirements.
Provision of eSource and eRegulatory systems that allow partners real-time access to study data and regulatory records.
Organization and hosting of informational talks, webinars and participation in community events to provide education on brain health, risk factors and research participation.
Expertise Areas
- Clinical trial management (Phases I–IV)
- Neurocognitive assessment and diagnostic evaluation
- Regulatory compliance with Health Canada and research ethics
- Electronic clinical data management (eSource/eRegulatory)
Key Technologies
- Electronic clinical research management systems (eSource, eRegulatory)
- Standardized cognitive assessment batteries
- On-site sample preparation laboratory workflows
- Clinical trial pharmacy and investigational product handling
News & Updates
A talk exploring hormonal changes during perimenopause and menopause affecting cognitive function and Alzheimer’s risk.
Early detection of neurocognitive disorders like Alzheimer’s can slow progression and improve lives.
Distinguishing normal aging memory loss from serious neurocognitive disorders such as Alzheimer’s.
Persistent symptoms over 6 months should prompt consultation with a doctor.
An alarming increase in neurocognitive disorders in Canada projected by 2050.
A new treatment for Alzheimer’s being tested in San Diego.
A talk exploring hormonal changes during perimenopause and menopause affecting cognitive function and Alzheimer’s risk.
Early detection of neurocognitive disorders like Alzheimer’s can slow progression and improve lives.
Distinguishing normal aging memory loss from serious neurocognitive disorders such as Alzheimer’s.
Persistent symptoms over 6 months should prompt consultation with a doctor.
An alarming increase in neurocognitive disorders in Canada projected by 2050.
A new treatment for Alzheimer’s being tested in San Diego.